Fed. Circ. Sends Xencor Antibody Patent Case Back To USPTO
By Adam Lidgett · January 23, 2024, 5:26 PM EST
The Federal Circuit has granted the U.S. Patent and Trademark Office's bid to send Xencor Inc.'s application for an antibody patent back for further proceedings to a new administrative appellate panel....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login